Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]Code Context
trigger_error($message, E_USER_DEPRECATED);
}
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.' $stackFrame = (int) 1 $trace = [ (int) 0 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php', 'line' => (int) 2421, 'function' => 'deprecationWarning', 'args' => [ (int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.' ] ], (int) 1 => [ 'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php', 'line' => (int) 73, 'function' => 'offsetGet', 'class' => 'Cake\Http\ServerRequest', 'object' => object(Cake\Http\ServerRequest) {}, 'type' => '->', 'args' => [ (int) 0 => 'catslug' ] ], (int) 2 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php', 'line' => (int) 610, 'function' => 'printArticle', 'class' => 'App\Controller\ArtileDetailController', 'object' => object(App\Controller\ArtileDetailController) {}, 'type' => '->', 'args' => [] ], (int) 3 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php', 'line' => (int) 120, 'function' => 'invokeAction', 'class' => 'Cake\Controller\Controller', 'object' => object(App\Controller\ArtileDetailController) {}, 'type' => '->', 'args' => [] ], (int) 4 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php', 'line' => (int) 94, 'function' => '_invoke', 'class' => 'Cake\Http\ActionDispatcher', 'object' => object(Cake\Http\ActionDispatcher) {}, 'type' => '->', 'args' => [ (int) 0 => object(App\Controller\ArtileDetailController) {} ] ], (int) 5 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php', 'line' => (int) 235, 'function' => 'dispatch', 'class' => 'Cake\Http\ActionDispatcher', 'object' => object(Cake\Http\ActionDispatcher) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 6 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Http\BaseApplication', 'object' => object(App\Application) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 7 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php', 'line' => (int) 162, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 8 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Routing\Middleware\RoutingMiddleware', 'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 9 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php', 'line' => (int) 88, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 10 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Routing\Middleware\AssetMiddleware', 'object' => object(Cake\Routing\Middleware\AssetMiddleware) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 11 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php', 'line' => (int) 96, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 12 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware', 'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 13 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 51, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 14 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php', 'line' => (int) 98, 'function' => 'run', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\MiddlewareQueue) {}, (int) 1 => object(Cake\Http\ServerRequest) {}, (int) 2 => object(Cake\Http\Response) {} ] ], (int) 15 => [ 'file' => '/home/brlfuser/public_html/webroot/index.php', 'line' => (int) 39, 'function' => 'run', 'class' => 'Cake\Http\Server', 'object' => object(Cake\Http\Server) {}, 'type' => '->', 'args' => [] ] ] $frame = [ 'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php', 'line' => (int) 73, 'function' => 'offsetGet', 'class' => 'Cake\Http\ServerRequest', 'object' => object(Cake\Http\ServerRequest) { trustProxy => false [protected] params => [ [maximum depth reached] ] [protected] data => [[maximum depth reached]] [protected] query => [[maximum depth reached]] [protected] cookies => [ [maximum depth reached] ] [protected] _environment => [ [maximum depth reached] ] [protected] url => 'latest-news-updates/un-health-agency-pushes-for-better-monitoring-of-anti-malaria-drugs-4401/print' [protected] base => '' [protected] webroot => '/' [protected] here => '/latest-news-updates/un-health-agency-pushes-for-better-monitoring-of-anti-malaria-drugs-4401/print' [protected] trustedProxies => [[maximum depth reached]] [protected] _input => null [protected] _detectors => [ [maximum depth reached] ] [protected] _detectorCache => [ [maximum depth reached] ] [protected] stream => object(Zend\Diactoros\PhpInputStream) {} [protected] uri => object(Zend\Diactoros\Uri) {} [protected] session => object(Cake\Http\Session) {} [protected] attributes => [[maximum depth reached]] [protected] emulatedAttributes => [ [maximum depth reached] ] [protected] uploadedFiles => [[maximum depth reached]] [protected] protocol => null [protected] requestTarget => null [private] deprecatedProperties => [ [maximum depth reached] ] }, 'type' => '->', 'args' => [ (int) 0 => 'catslug' ] ]deprecationWarning - CORE/src/Core/functions.php, line 311 Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421 App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 73 Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610 Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120 Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94 Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51 Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98
Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]Code Context
trigger_error($message, E_USER_DEPRECATED);
}
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.' $stackFrame = (int) 1 $trace = [ (int) 0 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php', 'line' => (int) 2421, 'function' => 'deprecationWarning', 'args' => [ (int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.' ] ], (int) 1 => [ 'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php', 'line' => (int) 74, 'function' => 'offsetGet', 'class' => 'Cake\Http\ServerRequest', 'object' => object(Cake\Http\ServerRequest) {}, 'type' => '->', 'args' => [ (int) 0 => 'artileslug' ] ], (int) 2 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php', 'line' => (int) 610, 'function' => 'printArticle', 'class' => 'App\Controller\ArtileDetailController', 'object' => object(App\Controller\ArtileDetailController) {}, 'type' => '->', 'args' => [] ], (int) 3 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php', 'line' => (int) 120, 'function' => 'invokeAction', 'class' => 'Cake\Controller\Controller', 'object' => object(App\Controller\ArtileDetailController) {}, 'type' => '->', 'args' => [] ], (int) 4 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php', 'line' => (int) 94, 'function' => '_invoke', 'class' => 'Cake\Http\ActionDispatcher', 'object' => object(Cake\Http\ActionDispatcher) {}, 'type' => '->', 'args' => [ (int) 0 => object(App\Controller\ArtileDetailController) {} ] ], (int) 5 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php', 'line' => (int) 235, 'function' => 'dispatch', 'class' => 'Cake\Http\ActionDispatcher', 'object' => object(Cake\Http\ActionDispatcher) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 6 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Http\BaseApplication', 'object' => object(App\Application) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 7 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php', 'line' => (int) 162, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 8 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Routing\Middleware\RoutingMiddleware', 'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 9 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php', 'line' => (int) 88, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 10 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Routing\Middleware\AssetMiddleware', 'object' => object(Cake\Routing\Middleware\AssetMiddleware) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 11 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php', 'line' => (int) 96, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 12 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware', 'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 13 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 51, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 14 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php', 'line' => (int) 98, 'function' => 'run', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\MiddlewareQueue) {}, (int) 1 => object(Cake\Http\ServerRequest) {}, (int) 2 => object(Cake\Http\Response) {} ] ], (int) 15 => [ 'file' => '/home/brlfuser/public_html/webroot/index.php', 'line' => (int) 39, 'function' => 'run', 'class' => 'Cake\Http\Server', 'object' => object(Cake\Http\Server) {}, 'type' => '->', 'args' => [] ] ] $frame = [ 'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php', 'line' => (int) 74, 'function' => 'offsetGet', 'class' => 'Cake\Http\ServerRequest', 'object' => object(Cake\Http\ServerRequest) { trustProxy => false [protected] params => [ [maximum depth reached] ] [protected] data => [[maximum depth reached]] [protected] query => [[maximum depth reached]] [protected] cookies => [ [maximum depth reached] ] [protected] _environment => [ [maximum depth reached] ] [protected] url => 'latest-news-updates/un-health-agency-pushes-for-better-monitoring-of-anti-malaria-drugs-4401/print' [protected] base => '' [protected] webroot => '/' [protected] here => '/latest-news-updates/un-health-agency-pushes-for-better-monitoring-of-anti-malaria-drugs-4401/print' [protected] trustedProxies => [[maximum depth reached]] [protected] _input => null [protected] _detectors => [ [maximum depth reached] ] [protected] _detectorCache => [ [maximum depth reached] ] [protected] stream => object(Zend\Diactoros\PhpInputStream) {} [protected] uri => object(Zend\Diactoros\Uri) {} [protected] session => object(Cake\Http\Session) {} [protected] attributes => [[maximum depth reached]] [protected] emulatedAttributes => [ [maximum depth reached] ] [protected] uploadedFiles => [[maximum depth reached]] [protected] protocol => null [protected] requestTarget => null [private] deprecatedProperties => [ [maximum depth reached] ] }, 'type' => '->', 'args' => [ (int) 0 => 'artileslug' ] ]deprecationWarning - CORE/src/Core/functions.php, line 311 Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421 App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 74 Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610 Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120 Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94 Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51 Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98
Warning (512): Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853 [CORE/src/Http/ResponseEmitter.php, line 48]Code Contextif (Configure::read('debug')) {
trigger_error($message, E_USER_WARNING);
} else {
$response = object(Cake\Http\Response) { 'status' => (int) 200, 'contentType' => 'text/html', 'headers' => [ 'Content-Type' => [ [maximum depth reached] ] ], 'file' => null, 'fileRange' => [], 'cookies' => object(Cake\Http\Cookie\CookieCollection) {}, 'cacheDirectives' => [], 'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd"> <html xmlns="http://www.w3.org/1999/xhtml"> <head> <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr68109c0a42cd5-trace').style.display = (document.getElementById('cakeErr68109c0a42cd5-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr68109c0a42cd5-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr68109c0a42cd5-code').style.display = (document.getElementById('cakeErr68109c0a42cd5-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr68109c0a42cd5-context').style.display = (document.getElementById('cakeErr68109c0a42cd5-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr68109c0a42cd5-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700"><</span><span style="color: #0000BB">head</span><span style="color: #007700">> </span></span></code> <span class="code-highlight"><code><span style="color: #000000"> <link rel="canonical" href="<span style="color: #0000BB"><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">); </span><span style="color: #0000BB">?><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-></span><span style="color: #0000BB">category</span><span style="color: #007700">-></span><span style="color: #0000BB">slug</span><span style="color: #007700">; </span><span style="color: #0000BB">?></span>/<span style="color: #0000BB"><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-></span><span style="color: #0000BB">seo_url</span><span style="color: #007700">; </span><span style="color: #0000BB">?></span>.html"/> </span></code></span> <code><span style="color: #000000"><span style="color: #0000BB"> </span><span style="color: #007700"><</span><span style="color: #0000BB">meta http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type" </span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html; charset=utf-8"</span><span style="color: #007700">/> </span></span></code></pre><pre id="cakeErr68109c0a42cd5-context" class="cake-context" style="display: none;">$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp' $dataForView = [ 'article_current' => object(App\Model\Entity\Article) { 'id' => (int) 4310, 'title' => 'UN health agency pushes for better monitoring of anti-malaria drugs', 'subheading' => '', 'description' => '<font face="arial,helvetica,sans-serif" size="3"><br /> </font> <div align="justify"> <font face="arial,helvetica,sans-serif" size="3">Only 34 per cent of countries with endemic malaria are complying with United Nations World Health Organization (WHO) recommendations to routinely monitor anti-malarial medicines, according to a report released today.</font><br /> <br /> <font face="arial,helvetica,sans-serif" size="3">The agency&rsquo;s &ldquo;Global report on anti-malarial drug efficacy and drug resistance: 2000-2010&rdquo; urges countries to be more vigilant in drug monitoring to allow for earlier detection of resistance to anti-malarial treatments.</font><br /> <br /> <font face="arial,helvetica,sans-serif" size="3">&ldquo;A greater political commitment to support and sustain national monitoring of the efficacy of anti-malarial medicines is critical to prevent a wider emergence of artemisinin resistance,&rdquo; said Dr. Pascal Ringwald of the Drug Resistance and Containment Unit, within WHO&rsquo;s Global Malaria Programme and one of the report&rsquo;s authors.</font><br /> <br /> <font face="arial,helvetica,sans-serif" size="3">Artemisinin is currently the most effective treatment against malaria, but resistance to the drug when used alone to treat the disease was found in February 2009 on the Cambodia-Thailand border.</font><br /> <br /> <font face="arial,helvetica,sans-serif" size="3">&ldquo;The emergence of artemisinin resistance on the Cambodia-Thailand border has been a wake-up call to the world to prevent its spread, increase monitoring, and preserve ACTs (Artemisinin-based Combination Therapy) as the only effective treatment we have for falciparum malaria,&rdquo; said Dr. Robert Newman, Director of WHO&rsquo;s Global Malaria Programme.</font><br /> <br /> <font face="arial,helvetica,sans-serif" size="3">Although efforts to contain the spread of artemisinin resistance on the Cambodia-Thailand border are ongoing, early evidence suggests the emergence of resistance on the Myanmar-Thailand border. There is also concern that this resistance could spread from Asia to Africa, as happened with other treatments in the 1960s and 70s.</font><br /> <br /> <font face="arial,helvetica,sans-serif" size="3">&ldquo;Anti-malarial drug resistance is like a cancer, it must be fought at every level,&rdquo; said Nicholas J White, Professor at the Mahidol-Oxford Research Unit in Bangkok, Thailand. &ldquo;Affected countries need to be in the frontline in combating the emergence of drug resistance. WHO should be empowered and supported to take a strong lead. It is crucial to protect ACTs as they are the best treatments for millions of people against malaria.&rdquo;</font><br /> <br /> <font face="arial,helvetica,sans-serif" size="3">The report found that ACTs currently recommended by national malaria control programmes remain effective against malaria, with cure rates generally above 90 per cent. In countries with cure rates lower than 90 per cent, policy change is ongoing to implement efficacious replacement malaria treatments.</font><br /> <br /> <font face="arial,helvetica,sans-serif" size="3">The use of artemisinin monotherapy is considered an important factor in the survival and spread of drug resistant strains. If the efficacy of the artemisinin component continues to decline, the risk grows of increased resistance to other drugs used in the combination.</font><br /> <br /> <font face="arial,helvetica,sans-serif" size="3">In response to the findings in the report, WHO is working with partners to develop a Global Plan for Artemisinin Resistance Containment, which will be released in January 2011. On World Health Day 2011, WHO will launch a public awareness campaign on antimicrobial resistance and its global spread, calling on governments and stakeholders to implement the policies and practices needed to safeguard medicines for future generations.</font><br /> <br /> </div>', 'credit_writer' => 'The United Nations, 18 November, 2010, http://www.un.org/apps/news/story.asp?NewsID=36794&Cr=malaria&Cr1=', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'un-health-agency-pushes-for-better-monitoring-of-anti-malaria-drugs-4401', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 4401, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [ [maximum depth reached] ], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ [maximum depth reached] ], '[dirty]' => [[maximum depth reached]], '[original]' => [[maximum depth reached]], '[virtual]' => [[maximum depth reached]], '[hasErrors]' => false, '[errors]' => [[maximum depth reached]], '[invalid]' => [[maximum depth reached]], '[repository]' => 'Articles' }, 'articleid' => (int) 4310, 'metaTitle' => 'LATEST NEWS UPDATES | UN health agency pushes for better monitoring of anti-malaria drugs', 'metaKeywords' => 'Health', 'metaDesc' => ' Only 34 per cent of countries with endemic malaria are complying with United Nations World Health Organization (WHO) recommendations to routinely monitor anti-malarial medicines, according to a report released today. The agency&rsquo;s &ldquo;Global report on anti-malarial drug efficacy and drug resistance:...', 'disp' => '<font ><br /></font><div align="justify"><font >Only 34 per cent of countries with endemic malaria are complying with United Nations World Health Organization (WHO) recommendations to routinely monitor anti-malarial medicines, according to a report released today.</font><br /><br /><font >The agency&rsquo;s &ldquo;Global report on anti-malarial drug efficacy and drug resistance: 2000-2010&rdquo; urges countries to be more vigilant in drug monitoring to allow for earlier detection of resistance to anti-malarial treatments.</font><br /><br /><font >&ldquo;A greater political commitment to support and sustain national monitoring of the efficacy of anti-malarial medicines is critical to prevent a wider emergence of artemisinin resistance,&rdquo; said Dr. Pascal Ringwald of the Drug Resistance and Containment Unit, within WHO&rsquo;s Global Malaria Programme and one of the report&rsquo;s authors.</font><br /><br /><font >Artemisinin is currently the most effective treatment against malaria, but resistance to the drug when used alone to treat the disease was found in February 2009 on the Cambodia-Thailand border.</font><br /><br /><font >&ldquo;The emergence of artemisinin resistance on the Cambodia-Thailand border has been a wake-up call to the world to prevent its spread, increase monitoring, and preserve ACTs (Artemisinin-based Combination Therapy) as the only effective treatment we have for falciparum malaria,&rdquo; said Dr. Robert Newman, Director of WHO&rsquo;s Global Malaria Programme.</font><br /><br /><font >Although efforts to contain the spread of artemisinin resistance on the Cambodia-Thailand border are ongoing, early evidence suggests the emergence of resistance on the Myanmar-Thailand border. There is also concern that this resistance could spread from Asia to Africa, as happened with other treatments in the 1960s and 70s.</font><br /><br /><font >&ldquo;Anti-malarial drug resistance is like a cancer, it must be fought at every level,&rdquo; said Nicholas J White, Professor at the Mahidol-Oxford Research Unit in Bangkok, Thailand. &ldquo;Affected countries need to be in the frontline in combating the emergence of drug resistance. WHO should be empowered and supported to take a strong lead. It is crucial to protect ACTs as they are the best treatments for millions of people against malaria.&rdquo;</font><br /><br /><font >The report found that ACTs currently recommended by national malaria control programmes remain effective against malaria, with cure rates generally above 90 per cent. In countries with cure rates lower than 90 per cent, policy change is ongoing to implement efficacious replacement malaria treatments.</font><br /><br /><font >The use of artemisinin monotherapy is considered an important factor in the survival and spread of drug resistant strains. If the efficacy of the artemisinin component continues to decline, the risk grows of increased resistance to other drugs used in the combination.</font><br /><br /><font >In response to the findings in the report, WHO is working with partners to develop a Global Plan for Artemisinin Resistance Containment, which will be released in January 2011. On World Health Day 2011, WHO will launch a public awareness campaign on antimicrobial resistance and its global spread, calling on governments and stakeholders to implement the policies and practices needed to safeguard medicines for future generations.</font><br /><br /></div>', 'lang' => 'English', 'SITE_URL' => 'https://im4change.in/', 'site_title' => 'im4change', 'adminprix' => 'admin' ] $article_current = object(App\Model\Entity\Article) { 'id' => (int) 4310, 'title' => 'UN health agency pushes for better monitoring of anti-malaria drugs', 'subheading' => '', 'description' => '<font face="arial,helvetica,sans-serif" size="3"><br /> </font> <div align="justify"> <font face="arial,helvetica,sans-serif" size="3">Only 34 per cent of countries with endemic malaria are complying with United Nations World Health Organization (WHO) recommendations to routinely monitor anti-malarial medicines, according to a report released today.</font><br /> <br /> <font face="arial,helvetica,sans-serif" size="3">The agency&rsquo;s &ldquo;Global report on anti-malarial drug efficacy and drug resistance: 2000-2010&rdquo; urges countries to be more vigilant in drug monitoring to allow for earlier detection of resistance to anti-malarial treatments.</font><br /> <br /> <font face="arial,helvetica,sans-serif" size="3">&ldquo;A greater political commitment to support and sustain national monitoring of the efficacy of anti-malarial medicines is critical to prevent a wider emergence of artemisinin resistance,&rdquo; said Dr. Pascal Ringwald of the Drug Resistance and Containment Unit, within WHO&rsquo;s Global Malaria Programme and one of the report&rsquo;s authors.</font><br /> <br /> <font face="arial,helvetica,sans-serif" size="3">Artemisinin is currently the most effective treatment against malaria, but resistance to the drug when used alone to treat the disease was found in February 2009 on the Cambodia-Thailand border.</font><br /> <br /> <font face="arial,helvetica,sans-serif" size="3">&ldquo;The emergence of artemisinin resistance on the Cambodia-Thailand border has been a wake-up call to the world to prevent its spread, increase monitoring, and preserve ACTs (Artemisinin-based Combination Therapy) as the only effective treatment we have for falciparum malaria,&rdquo; said Dr. Robert Newman, Director of WHO&rsquo;s Global Malaria Programme.</font><br /> <br /> <font face="arial,helvetica,sans-serif" size="3">Although efforts to contain the spread of artemisinin resistance on the Cambodia-Thailand border are ongoing, early evidence suggests the emergence of resistance on the Myanmar-Thailand border. There is also concern that this resistance could spread from Asia to Africa, as happened with other treatments in the 1960s and 70s.</font><br /> <br /> <font face="arial,helvetica,sans-serif" size="3">&ldquo;Anti-malarial drug resistance is like a cancer, it must be fought at every level,&rdquo; said Nicholas J White, Professor at the Mahidol-Oxford Research Unit in Bangkok, Thailand. &ldquo;Affected countries need to be in the frontline in combating the emergence of drug resistance. WHO should be empowered and supported to take a strong lead. It is crucial to protect ACTs as they are the best treatments for millions of people against malaria.&rdquo;</font><br /> <br /> <font face="arial,helvetica,sans-serif" size="3">The report found that ACTs currently recommended by national malaria control programmes remain effective against malaria, with cure rates generally above 90 per cent. In countries with cure rates lower than 90 per cent, policy change is ongoing to implement efficacious replacement malaria treatments.</font><br /> <br /> <font face="arial,helvetica,sans-serif" size="3">The use of artemisinin monotherapy is considered an important factor in the survival and spread of drug resistant strains. If the efficacy of the artemisinin component continues to decline, the risk grows of increased resistance to other drugs used in the combination.</font><br /> <br /> <font face="arial,helvetica,sans-serif" size="3">In response to the findings in the report, WHO is working with partners to develop a Global Plan for Artemisinin Resistance Containment, which will be released in January 2011. On World Health Day 2011, WHO will launch a public awareness campaign on antimicrobial resistance and its global spread, calling on governments and stakeholders to implement the policies and practices needed to safeguard medicines for future generations.</font><br /> <br /> </div>', 'credit_writer' => 'The United Nations, 18 November, 2010, http://www.un.org/apps/news/story.asp?NewsID=36794&Cr=malaria&Cr1=', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'un-health-agency-pushes-for-better-monitoring-of-anti-malaria-drugs-4401', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 4401, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [ (int) 0 => object(Cake\ORM\Entity) {} ], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ '*' => true, 'id' => false ], '[dirty]' => [], '[original]' => [], '[virtual]' => [], '[hasErrors]' => false, '[errors]' => [], '[invalid]' => [], '[repository]' => 'Articles' } $articleid = (int) 4310 $metaTitle = 'LATEST NEWS UPDATES | UN health agency pushes for better monitoring of anti-malaria drugs' $metaKeywords = 'Health' $metaDesc = ' Only 34 per cent of countries with endemic malaria are complying with United Nations World Health Organization (WHO) recommendations to routinely monitor anti-malarial medicines, according to a report released today. The agency&rsquo;s &ldquo;Global report on anti-malarial drug efficacy and drug resistance:...' $disp = '<font ><br /></font><div align="justify"><font >Only 34 per cent of countries with endemic malaria are complying with United Nations World Health Organization (WHO) recommendations to routinely monitor anti-malarial medicines, according to a report released today.</font><br /><br /><font >The agency&rsquo;s &ldquo;Global report on anti-malarial drug efficacy and drug resistance: 2000-2010&rdquo; urges countries to be more vigilant in drug monitoring to allow for earlier detection of resistance to anti-malarial treatments.</font><br /><br /><font >&ldquo;A greater political commitment to support and sustain national monitoring of the efficacy of anti-malarial medicines is critical to prevent a wider emergence of artemisinin resistance,&rdquo; said Dr. Pascal Ringwald of the Drug Resistance and Containment Unit, within WHO&rsquo;s Global Malaria Programme and one of the report&rsquo;s authors.</font><br /><br /><font >Artemisinin is currently the most effective treatment against malaria, but resistance to the drug when used alone to treat the disease was found in February 2009 on the Cambodia-Thailand border.</font><br /><br /><font >&ldquo;The emergence of artemisinin resistance on the Cambodia-Thailand border has been a wake-up call to the world to prevent its spread, increase monitoring, and preserve ACTs (Artemisinin-based Combination Therapy) as the only effective treatment we have for falciparum malaria,&rdquo; said Dr. Robert Newman, Director of WHO&rsquo;s Global Malaria Programme.</font><br /><br /><font >Although efforts to contain the spread of artemisinin resistance on the Cambodia-Thailand border are ongoing, early evidence suggests the emergence of resistance on the Myanmar-Thailand border. There is also concern that this resistance could spread from Asia to Africa, as happened with other treatments in the 1960s and 70s.</font><br /><br /><font >&ldquo;Anti-malarial drug resistance is like a cancer, it must be fought at every level,&rdquo; said Nicholas J White, Professor at the Mahidol-Oxford Research Unit in Bangkok, Thailand. &ldquo;Affected countries need to be in the frontline in combating the emergence of drug resistance. WHO should be empowered and supported to take a strong lead. It is crucial to protect ACTs as they are the best treatments for millions of people against malaria.&rdquo;</font><br /><br /><font >The report found that ACTs currently recommended by national malaria control programmes remain effective against malaria, with cure rates generally above 90 per cent. In countries with cure rates lower than 90 per cent, policy change is ongoing to implement efficacious replacement malaria treatments.</font><br /><br /><font >The use of artemisinin monotherapy is considered an important factor in the survival and spread of drug resistant strains. If the efficacy of the artemisinin component continues to decline, the risk grows of increased resistance to other drugs used in the combination.</font><br /><br /><font >In response to the findings in the report, WHO is working with partners to develop a Global Plan for Artemisinin Resistance Containment, which will be released in January 2011. On World Health Day 2011, WHO will launch a public awareness campaign on antimicrobial resistance and its global spread, calling on governments and stakeholders to implement the policies and practices needed to safeguard medicines for future generations.</font><br /><br /></div>' $lang = 'English' $SITE_URL = 'https://im4change.in/' $site_title = 'im4change' $adminprix = 'admin'</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8 Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413 Cake\View\View::_render() - CORE/src/View/View.php, line 1374 Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927 Cake\View\View::render() - CORE/src/View/View.php, line 885 Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791 Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126 Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94 Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/un-health-agency-pushes-for-better-monitoring-of-anti-malaria-drugs-4401.html"/> <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/> <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css" media="all"/> <title>LATEST NEWS UPDATES | UN health agency pushes for better monitoring of anti-malaria drugs | Im4change.org</title> <meta name="description" content=" Only 34 per cent of countries with endemic malaria are complying with United Nations World Health Organization (WHO) recommendations to routinely monitor anti-malarial medicines, according to a report released today. The agency’s “Global report on anti-malarial drug efficacy and drug resistance:..."/> <script src="https://im4change.in/js/jquery-1.10.2.js"></script> <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script> <script language="javascript" type="text/javascript"> $(document).ready(function () { var img = $("img")[0]; // Get my img elem var pic_real_width, pic_real_height; $("<img/>") // Make in memory copy of image to avoid css issues .attr("src", $(img).attr("src")) .load(function () { pic_real_width = this.width; // Note: $(this).width() will not pic_real_height = this.height; // work for in memory images. }); }); </script> <style type="text/css"> @media screen { div.divFooter { display: block; } } @media print { .printbutton { display: none !important; } } </style> </head> <body> <table cellpadding="0" cellspacing="0" border="0" width="98%" align="center"> <tr> <td class="top_bg"> <div class="divFooter"> <img src="https://im4change.in/images/logo1.jpg" height="59" border="0" alt="Resource centre on India's rural distress" style="padding-top:14px;"/> </div> </td> </tr> <tr> <td id="topspace"> </td> </tr> <tr id="topspace"> <td> </td> </tr> <tr> <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton"> <form><input type="button" value=" Print this page " onclick="window.print();return false;"/></form> </td> </tr> <tr> <td width="100%"> <h1 class="news_headlines" style="font-style:normal"> <strong>UN health agency pushes for better monitoring of anti-malaria drugs</strong></h1> </td> </tr> <tr> <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3"> <font ><br /></font><div align="justify"><font >Only 34 per cent of countries with endemic malaria are complying with United Nations World Health Organization (WHO) recommendations to routinely monitor anti-malarial medicines, according to a report released today.</font><br /><br /><font >The agency’s “Global report on anti-malarial drug efficacy and drug resistance: 2000-2010” urges countries to be more vigilant in drug monitoring to allow for earlier detection of resistance to anti-malarial treatments.</font><br /><br /><font >“A greater political commitment to support and sustain national monitoring of the efficacy of anti-malarial medicines is critical to prevent a wider emergence of artemisinin resistance,” said Dr. Pascal Ringwald of the Drug Resistance and Containment Unit, within WHO’s Global Malaria Programme and one of the report’s authors.</font><br /><br /><font >Artemisinin is currently the most effective treatment against malaria, but resistance to the drug when used alone to treat the disease was found in February 2009 on the Cambodia-Thailand border.</font><br /><br /><font >“The emergence of artemisinin resistance on the Cambodia-Thailand border has been a wake-up call to the world to prevent its spread, increase monitoring, and preserve ACTs (Artemisinin-based Combination Therapy) as the only effective treatment we have for falciparum malaria,” said Dr. Robert Newman, Director of WHO’s Global Malaria Programme.</font><br /><br /><font >Although efforts to contain the spread of artemisinin resistance on the Cambodia-Thailand border are ongoing, early evidence suggests the emergence of resistance on the Myanmar-Thailand border. There is also concern that this resistance could spread from Asia to Africa, as happened with other treatments in the 1960s and 70s.</font><br /><br /><font >“Anti-malarial drug resistance is like a cancer, it must be fought at every level,” said Nicholas J White, Professor at the Mahidol-Oxford Research Unit in Bangkok, Thailand. “Affected countries need to be in the frontline in combating the emergence of drug resistance. WHO should be empowered and supported to take a strong lead. It is crucial to protect ACTs as they are the best treatments for millions of people against malaria.”</font><br /><br /><font >The report found that ACTs currently recommended by national malaria control programmes remain effective against malaria, with cure rates generally above 90 per cent. In countries with cure rates lower than 90 per cent, policy change is ongoing to implement efficacious replacement malaria treatments.</font><br /><br /><font >The use of artemisinin monotherapy is considered an important factor in the survival and spread of drug resistant strains. If the efficacy of the artemisinin component continues to decline, the risk grows of increased resistance to other drugs used in the combination.</font><br /><br /><font >In response to the findings in the report, WHO is working with partners to develop a Global Plan for Artemisinin Resistance Containment, which will be released in January 2011. On World Health Day 2011, WHO will launch a public awareness campaign on antimicrobial resistance and its global spread, calling on governments and stakeholders to implement the policies and practices needed to safeguard medicines for future generations.</font><br /><br /></div> </font> </td> </tr> <tr> <td> </td> </tr> <tr> <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;"> <form><input type="button" value=" Print this page " onclick="window.print();return false;"/></form> </td> </tr> </table></body> </html>' } $maxBufferLength = (int) 8192 $file = '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php' $line = (int) 853 $message = 'Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853'Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 48 Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141 [main] - ROOT/webroot/index.php, line 39
Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 148]Code Context$response->getStatusCode(),
($reasonPhrase ? ' ' . $reasonPhrase : '')
));
$response = object(Cake\Http\Response) { 'status' => (int) 200, 'contentType' => 'text/html', 'headers' => [ 'Content-Type' => [ [maximum depth reached] ] ], 'file' => null, 'fileRange' => [], 'cookies' => object(Cake\Http\Cookie\CookieCollection) {}, 'cacheDirectives' => [], 'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd"> <html xmlns="http://www.w3.org/1999/xhtml"> <head> <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr68109c0a42cd5-trace').style.display = (document.getElementById('cakeErr68109c0a42cd5-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr68109c0a42cd5-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr68109c0a42cd5-code').style.display = (document.getElementById('cakeErr68109c0a42cd5-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr68109c0a42cd5-context').style.display = (document.getElementById('cakeErr68109c0a42cd5-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr68109c0a42cd5-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700"><</span><span style="color: #0000BB">head</span><span style="color: #007700">> </span></span></code> <span class="code-highlight"><code><span style="color: #000000"> <link rel="canonical" href="<span style="color: #0000BB"><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">); </span><span style="color: #0000BB">?><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-></span><span style="color: #0000BB">category</span><span style="color: #007700">-></span><span style="color: #0000BB">slug</span><span style="color: #007700">; </span><span style="color: #0000BB">?></span>/<span style="color: #0000BB"><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-></span><span style="color: #0000BB">seo_url</span><span style="color: #007700">; </span><span style="color: #0000BB">?></span>.html"/> </span></code></span> <code><span style="color: #000000"><span style="color: #0000BB"> </span><span style="color: #007700"><</span><span style="color: #0000BB">meta http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type" </span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html; charset=utf-8"</span><span style="color: #007700">/> </span></span></code></pre><pre id="cakeErr68109c0a42cd5-context" class="cake-context" style="display: none;">$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp' $dataForView = [ 'article_current' => object(App\Model\Entity\Article) { 'id' => (int) 4310, 'title' => 'UN health agency pushes for better monitoring of anti-malaria drugs', 'subheading' => '', 'description' => '<font face="arial,helvetica,sans-serif" size="3"><br /> </font> <div align="justify"> <font face="arial,helvetica,sans-serif" size="3">Only 34 per cent of countries with endemic malaria are complying with United Nations World Health Organization (WHO) recommendations to routinely monitor anti-malarial medicines, according to a report released today.</font><br /> <br /> <font face="arial,helvetica,sans-serif" size="3">The agency&rsquo;s &ldquo;Global report on anti-malarial drug efficacy and drug resistance: 2000-2010&rdquo; urges countries to be more vigilant in drug monitoring to allow for earlier detection of resistance to anti-malarial treatments.</font><br /> <br /> <font face="arial,helvetica,sans-serif" size="3">&ldquo;A greater political commitment to support and sustain national monitoring of the efficacy of anti-malarial medicines is critical to prevent a wider emergence of artemisinin resistance,&rdquo; said Dr. Pascal Ringwald of the Drug Resistance and Containment Unit, within WHO&rsquo;s Global Malaria Programme and one of the report&rsquo;s authors.</font><br /> <br /> <font face="arial,helvetica,sans-serif" size="3">Artemisinin is currently the most effective treatment against malaria, but resistance to the drug when used alone to treat the disease was found in February 2009 on the Cambodia-Thailand border.</font><br /> <br /> <font face="arial,helvetica,sans-serif" size="3">&ldquo;The emergence of artemisinin resistance on the Cambodia-Thailand border has been a wake-up call to the world to prevent its spread, increase monitoring, and preserve ACTs (Artemisinin-based Combination Therapy) as the only effective treatment we have for falciparum malaria,&rdquo; said Dr. Robert Newman, Director of WHO&rsquo;s Global Malaria Programme.</font><br /> <br /> <font face="arial,helvetica,sans-serif" size="3">Although efforts to contain the spread of artemisinin resistance on the Cambodia-Thailand border are ongoing, early evidence suggests the emergence of resistance on the Myanmar-Thailand border. There is also concern that this resistance could spread from Asia to Africa, as happened with other treatments in the 1960s and 70s.</font><br /> <br /> <font face="arial,helvetica,sans-serif" size="3">&ldquo;Anti-malarial drug resistance is like a cancer, it must be fought at every level,&rdquo; said Nicholas J White, Professor at the Mahidol-Oxford Research Unit in Bangkok, Thailand. &ldquo;Affected countries need to be in the frontline in combating the emergence of drug resistance. WHO should be empowered and supported to take a strong lead. It is crucial to protect ACTs as they are the best treatments for millions of people against malaria.&rdquo;</font><br /> <br /> <font face="arial,helvetica,sans-serif" size="3">The report found that ACTs currently recommended by national malaria control programmes remain effective against malaria, with cure rates generally above 90 per cent. In countries with cure rates lower than 90 per cent, policy change is ongoing to implement efficacious replacement malaria treatments.</font><br /> <br /> <font face="arial,helvetica,sans-serif" size="3">The use of artemisinin monotherapy is considered an important factor in the survival and spread of drug resistant strains. If the efficacy of the artemisinin component continues to decline, the risk grows of increased resistance to other drugs used in the combination.</font><br /> <br /> <font face="arial,helvetica,sans-serif" size="3">In response to the findings in the report, WHO is working with partners to develop a Global Plan for Artemisinin Resistance Containment, which will be released in January 2011. On World Health Day 2011, WHO will launch a public awareness campaign on antimicrobial resistance and its global spread, calling on governments and stakeholders to implement the policies and practices needed to safeguard medicines for future generations.</font><br /> <br /> </div>', 'credit_writer' => 'The United Nations, 18 November, 2010, http://www.un.org/apps/news/story.asp?NewsID=36794&Cr=malaria&Cr1=', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'un-health-agency-pushes-for-better-monitoring-of-anti-malaria-drugs-4401', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 4401, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [ [maximum depth reached] ], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ [maximum depth reached] ], '[dirty]' => [[maximum depth reached]], '[original]' => [[maximum depth reached]], '[virtual]' => [[maximum depth reached]], '[hasErrors]' => false, '[errors]' => [[maximum depth reached]], '[invalid]' => [[maximum depth reached]], '[repository]' => 'Articles' }, 'articleid' => (int) 4310, 'metaTitle' => 'LATEST NEWS UPDATES | UN health agency pushes for better monitoring of anti-malaria drugs', 'metaKeywords' => 'Health', 'metaDesc' => ' Only 34 per cent of countries with endemic malaria are complying with United Nations World Health Organization (WHO) recommendations to routinely monitor anti-malarial medicines, according to a report released today. The agency&rsquo;s &ldquo;Global report on anti-malarial drug efficacy and drug resistance:...', 'disp' => '<font ><br /></font><div align="justify"><font >Only 34 per cent of countries with endemic malaria are complying with United Nations World Health Organization (WHO) recommendations to routinely monitor anti-malarial medicines, according to a report released today.</font><br /><br /><font >The agency&rsquo;s &ldquo;Global report on anti-malarial drug efficacy and drug resistance: 2000-2010&rdquo; urges countries to be more vigilant in drug monitoring to allow for earlier detection of resistance to anti-malarial treatments.</font><br /><br /><font >&ldquo;A greater political commitment to support and sustain national monitoring of the efficacy of anti-malarial medicines is critical to prevent a wider emergence of artemisinin resistance,&rdquo; said Dr. Pascal Ringwald of the Drug Resistance and Containment Unit, within WHO&rsquo;s Global Malaria Programme and one of the report&rsquo;s authors.</font><br /><br /><font >Artemisinin is currently the most effective treatment against malaria, but resistance to the drug when used alone to treat the disease was found in February 2009 on the Cambodia-Thailand border.</font><br /><br /><font >&ldquo;The emergence of artemisinin resistance on the Cambodia-Thailand border has been a wake-up call to the world to prevent its spread, increase monitoring, and preserve ACTs (Artemisinin-based Combination Therapy) as the only effective treatment we have for falciparum malaria,&rdquo; said Dr. Robert Newman, Director of WHO&rsquo;s Global Malaria Programme.</font><br /><br /><font >Although efforts to contain the spread of artemisinin resistance on the Cambodia-Thailand border are ongoing, early evidence suggests the emergence of resistance on the Myanmar-Thailand border. There is also concern that this resistance could spread from Asia to Africa, as happened with other treatments in the 1960s and 70s.</font><br /><br /><font >&ldquo;Anti-malarial drug resistance is like a cancer, it must be fought at every level,&rdquo; said Nicholas J White, Professor at the Mahidol-Oxford Research Unit in Bangkok, Thailand. &ldquo;Affected countries need to be in the frontline in combating the emergence of drug resistance. WHO should be empowered and supported to take a strong lead. It is crucial to protect ACTs as they are the best treatments for millions of people against malaria.&rdquo;</font><br /><br /><font >The report found that ACTs currently recommended by national malaria control programmes remain effective against malaria, with cure rates generally above 90 per cent. In countries with cure rates lower than 90 per cent, policy change is ongoing to implement efficacious replacement malaria treatments.</font><br /><br /><font >The use of artemisinin monotherapy is considered an important factor in the survival and spread of drug resistant strains. If the efficacy of the artemisinin component continues to decline, the risk grows of increased resistance to other drugs used in the combination.</font><br /><br /><font >In response to the findings in the report, WHO is working with partners to develop a Global Plan for Artemisinin Resistance Containment, which will be released in January 2011. On World Health Day 2011, WHO will launch a public awareness campaign on antimicrobial resistance and its global spread, calling on governments and stakeholders to implement the policies and practices needed to safeguard medicines for future generations.</font><br /><br /></div>', 'lang' => 'English', 'SITE_URL' => 'https://im4change.in/', 'site_title' => 'im4change', 'adminprix' => 'admin' ] $article_current = object(App\Model\Entity\Article) { 'id' => (int) 4310, 'title' => 'UN health agency pushes for better monitoring of anti-malaria drugs', 'subheading' => '', 'description' => '<font face="arial,helvetica,sans-serif" size="3"><br /> </font> <div align="justify"> <font face="arial,helvetica,sans-serif" size="3">Only 34 per cent of countries with endemic malaria are complying with United Nations World Health Organization (WHO) recommendations to routinely monitor anti-malarial medicines, according to a report released today.</font><br /> <br /> <font face="arial,helvetica,sans-serif" size="3">The agency&rsquo;s &ldquo;Global report on anti-malarial drug efficacy and drug resistance: 2000-2010&rdquo; urges countries to be more vigilant in drug monitoring to allow for earlier detection of resistance to anti-malarial treatments.</font><br /> <br /> <font face="arial,helvetica,sans-serif" size="3">&ldquo;A greater political commitment to support and sustain national monitoring of the efficacy of anti-malarial medicines is critical to prevent a wider emergence of artemisinin resistance,&rdquo; said Dr. Pascal Ringwald of the Drug Resistance and Containment Unit, within WHO&rsquo;s Global Malaria Programme and one of the report&rsquo;s authors.</font><br /> <br /> <font face="arial,helvetica,sans-serif" size="3">Artemisinin is currently the most effective treatment against malaria, but resistance to the drug when used alone to treat the disease was found in February 2009 on the Cambodia-Thailand border.</font><br /> <br /> <font face="arial,helvetica,sans-serif" size="3">&ldquo;The emergence of artemisinin resistance on the Cambodia-Thailand border has been a wake-up call to the world to prevent its spread, increase monitoring, and preserve ACTs (Artemisinin-based Combination Therapy) as the only effective treatment we have for falciparum malaria,&rdquo; said Dr. Robert Newman, Director of WHO&rsquo;s Global Malaria Programme.</font><br /> <br /> <font face="arial,helvetica,sans-serif" size="3">Although efforts to contain the spread of artemisinin resistance on the Cambodia-Thailand border are ongoing, early evidence suggests the emergence of resistance on the Myanmar-Thailand border. There is also concern that this resistance could spread from Asia to Africa, as happened with other treatments in the 1960s and 70s.</font><br /> <br /> <font face="arial,helvetica,sans-serif" size="3">&ldquo;Anti-malarial drug resistance is like a cancer, it must be fought at every level,&rdquo; said Nicholas J White, Professor at the Mahidol-Oxford Research Unit in Bangkok, Thailand. &ldquo;Affected countries need to be in the frontline in combating the emergence of drug resistance. WHO should be empowered and supported to take a strong lead. It is crucial to protect ACTs as they are the best treatments for millions of people against malaria.&rdquo;</font><br /> <br /> <font face="arial,helvetica,sans-serif" size="3">The report found that ACTs currently recommended by national malaria control programmes remain effective against malaria, with cure rates generally above 90 per cent. In countries with cure rates lower than 90 per cent, policy change is ongoing to implement efficacious replacement malaria treatments.</font><br /> <br /> <font face="arial,helvetica,sans-serif" size="3">The use of artemisinin monotherapy is considered an important factor in the survival and spread of drug resistant strains. If the efficacy of the artemisinin component continues to decline, the risk grows of increased resistance to other drugs used in the combination.</font><br /> <br /> <font face="arial,helvetica,sans-serif" size="3">In response to the findings in the report, WHO is working with partners to develop a Global Plan for Artemisinin Resistance Containment, which will be released in January 2011. On World Health Day 2011, WHO will launch a public awareness campaign on antimicrobial resistance and its global spread, calling on governments and stakeholders to implement the policies and practices needed to safeguard medicines for future generations.</font><br /> <br /> </div>', 'credit_writer' => 'The United Nations, 18 November, 2010, http://www.un.org/apps/news/story.asp?NewsID=36794&Cr=malaria&Cr1=', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'un-health-agency-pushes-for-better-monitoring-of-anti-malaria-drugs-4401', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 4401, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [ (int) 0 => object(Cake\ORM\Entity) {} ], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ '*' => true, 'id' => false ], '[dirty]' => [], '[original]' => [], '[virtual]' => [], '[hasErrors]' => false, '[errors]' => [], '[invalid]' => [], '[repository]' => 'Articles' } $articleid = (int) 4310 $metaTitle = 'LATEST NEWS UPDATES | UN health agency pushes for better monitoring of anti-malaria drugs' $metaKeywords = 'Health' $metaDesc = ' Only 34 per cent of countries with endemic malaria are complying with United Nations World Health Organization (WHO) recommendations to routinely monitor anti-malarial medicines, according to a report released today. The agency&rsquo;s &ldquo;Global report on anti-malarial drug efficacy and drug resistance:...' $disp = '<font ><br /></font><div align="justify"><font >Only 34 per cent of countries with endemic malaria are complying with United Nations World Health Organization (WHO) recommendations to routinely monitor anti-malarial medicines, according to a report released today.</font><br /><br /><font >The agency&rsquo;s &ldquo;Global report on anti-malarial drug efficacy and drug resistance: 2000-2010&rdquo; urges countries to be more vigilant in drug monitoring to allow for earlier detection of resistance to anti-malarial treatments.</font><br /><br /><font >&ldquo;A greater political commitment to support and sustain national monitoring of the efficacy of anti-malarial medicines is critical to prevent a wider emergence of artemisinin resistance,&rdquo; said Dr. Pascal Ringwald of the Drug Resistance and Containment Unit, within WHO&rsquo;s Global Malaria Programme and one of the report&rsquo;s authors.</font><br /><br /><font >Artemisinin is currently the most effective treatment against malaria, but resistance to the drug when used alone to treat the disease was found in February 2009 on the Cambodia-Thailand border.</font><br /><br /><font >&ldquo;The emergence of artemisinin resistance on the Cambodia-Thailand border has been a wake-up call to the world to prevent its spread, increase monitoring, and preserve ACTs (Artemisinin-based Combination Therapy) as the only effective treatment we have for falciparum malaria,&rdquo; said Dr. Robert Newman, Director of WHO&rsquo;s Global Malaria Programme.</font><br /><br /><font >Although efforts to contain the spread of artemisinin resistance on the Cambodia-Thailand border are ongoing, early evidence suggests the emergence of resistance on the Myanmar-Thailand border. There is also concern that this resistance could spread from Asia to Africa, as happened with other treatments in the 1960s and 70s.</font><br /><br /><font >&ldquo;Anti-malarial drug resistance is like a cancer, it must be fought at every level,&rdquo; said Nicholas J White, Professor at the Mahidol-Oxford Research Unit in Bangkok, Thailand. &ldquo;Affected countries need to be in the frontline in combating the emergence of drug resistance. WHO should be empowered and supported to take a strong lead. It is crucial to protect ACTs as they are the best treatments for millions of people against malaria.&rdquo;</font><br /><br /><font >The report found that ACTs currently recommended by national malaria control programmes remain effective against malaria, with cure rates generally above 90 per cent. In countries with cure rates lower than 90 per cent, policy change is ongoing to implement efficacious replacement malaria treatments.</font><br /><br /><font >The use of artemisinin monotherapy is considered an important factor in the survival and spread of drug resistant strains. If the efficacy of the artemisinin component continues to decline, the risk grows of increased resistance to other drugs used in the combination.</font><br /><br /><font >In response to the findings in the report, WHO is working with partners to develop a Global Plan for Artemisinin Resistance Containment, which will be released in January 2011. On World Health Day 2011, WHO will launch a public awareness campaign on antimicrobial resistance and its global spread, calling on governments and stakeholders to implement the policies and practices needed to safeguard medicines for future generations.</font><br /><br /></div>' $lang = 'English' $SITE_URL = 'https://im4change.in/' $site_title = 'im4change' $adminprix = 'admin'</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8 Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413 Cake\View\View::_render() - CORE/src/View/View.php, line 1374 Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927 Cake\View\View::render() - CORE/src/View/View.php, line 885 Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791 Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126 Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94 Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/un-health-agency-pushes-for-better-monitoring-of-anti-malaria-drugs-4401.html"/> <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/> <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css" media="all"/> <title>LATEST NEWS UPDATES | UN health agency pushes for better monitoring of anti-malaria drugs | Im4change.org</title> <meta name="description" content=" Only 34 per cent of countries with endemic malaria are complying with United Nations World Health Organization (WHO) recommendations to routinely monitor anti-malarial medicines, according to a report released today. The agency’s “Global report on anti-malarial drug efficacy and drug resistance:..."/> <script src="https://im4change.in/js/jquery-1.10.2.js"></script> <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script> <script language="javascript" type="text/javascript"> $(document).ready(function () { var img = $("img")[0]; // Get my img elem var pic_real_width, pic_real_height; $("<img/>") // Make in memory copy of image to avoid css issues .attr("src", $(img).attr("src")) .load(function () { pic_real_width = this.width; // Note: $(this).width() will not pic_real_height = this.height; // work for in memory images. }); }); </script> <style type="text/css"> @media screen { div.divFooter { display: block; } } @media print { .printbutton { display: none !important; } } </style> </head> <body> <table cellpadding="0" cellspacing="0" border="0" width="98%" align="center"> <tr> <td class="top_bg"> <div class="divFooter"> <img src="https://im4change.in/images/logo1.jpg" height="59" border="0" alt="Resource centre on India's rural distress" style="padding-top:14px;"/> </div> </td> </tr> <tr> <td id="topspace"> </td> </tr> <tr id="topspace"> <td> </td> </tr> <tr> <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton"> <form><input type="button" value=" Print this page " onclick="window.print();return false;"/></form> </td> </tr> <tr> <td width="100%"> <h1 class="news_headlines" style="font-style:normal"> <strong>UN health agency pushes for better monitoring of anti-malaria drugs</strong></h1> </td> </tr> <tr> <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3"> <font ><br /></font><div align="justify"><font >Only 34 per cent of countries with endemic malaria are complying with United Nations World Health Organization (WHO) recommendations to routinely monitor anti-malarial medicines, according to a report released today.</font><br /><br /><font >The agency’s “Global report on anti-malarial drug efficacy and drug resistance: 2000-2010” urges countries to be more vigilant in drug monitoring to allow for earlier detection of resistance to anti-malarial treatments.</font><br /><br /><font >“A greater political commitment to support and sustain national monitoring of the efficacy of anti-malarial medicines is critical to prevent a wider emergence of artemisinin resistance,” said Dr. Pascal Ringwald of the Drug Resistance and Containment Unit, within WHO’s Global Malaria Programme and one of the report’s authors.</font><br /><br /><font >Artemisinin is currently the most effective treatment against malaria, but resistance to the drug when used alone to treat the disease was found in February 2009 on the Cambodia-Thailand border.</font><br /><br /><font >“The emergence of artemisinin resistance on the Cambodia-Thailand border has been a wake-up call to the world to prevent its spread, increase monitoring, and preserve ACTs (Artemisinin-based Combination Therapy) as the only effective treatment we have for falciparum malaria,” said Dr. Robert Newman, Director of WHO’s Global Malaria Programme.</font><br /><br /><font >Although efforts to contain the spread of artemisinin resistance on the Cambodia-Thailand border are ongoing, early evidence suggests the emergence of resistance on the Myanmar-Thailand border. There is also concern that this resistance could spread from Asia to Africa, as happened with other treatments in the 1960s and 70s.</font><br /><br /><font >“Anti-malarial drug resistance is like a cancer, it must be fought at every level,” said Nicholas J White, Professor at the Mahidol-Oxford Research Unit in Bangkok, Thailand. “Affected countries need to be in the frontline in combating the emergence of drug resistance. WHO should be empowered and supported to take a strong lead. It is crucial to protect ACTs as they are the best treatments for millions of people against malaria.”</font><br /><br /><font >The report found that ACTs currently recommended by national malaria control programmes remain effective against malaria, with cure rates generally above 90 per cent. In countries with cure rates lower than 90 per cent, policy change is ongoing to implement efficacious replacement malaria treatments.</font><br /><br /><font >The use of artemisinin monotherapy is considered an important factor in the survival and spread of drug resistant strains. If the efficacy of the artemisinin component continues to decline, the risk grows of increased resistance to other drugs used in the combination.</font><br /><br /><font >In response to the findings in the report, WHO is working with partners to develop a Global Plan for Artemisinin Resistance Containment, which will be released in January 2011. On World Health Day 2011, WHO will launch a public awareness campaign on antimicrobial resistance and its global spread, calling on governments and stakeholders to implement the policies and practices needed to safeguard medicines for future generations.</font><br /><br /></div> </font> </td> </tr> <tr> <td> </td> </tr> <tr> <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;"> <form><input type="button" value=" Print this page " onclick="window.print();return false;"/></form> </td> </tr> </table></body> </html>' } $reasonPhrase = 'OK'header - [internal], line ?? Cake\Http\ResponseEmitter::emitStatusLine() - CORE/src/Http/ResponseEmitter.php, line 148 Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 54 Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141 [main] - ROOT/webroot/index.php, line 39
Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 181]Notice (8): Undefined variable: urlPrefix [APP/Template/Layout/printlayout.ctp, line 8]Code Context$value
), $first);
$first = false;
$response = object(Cake\Http\Response) { 'status' => (int) 200, 'contentType' => 'text/html', 'headers' => [ 'Content-Type' => [ [maximum depth reached] ] ], 'file' => null, 'fileRange' => [], 'cookies' => object(Cake\Http\Cookie\CookieCollection) {}, 'cacheDirectives' => [], 'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd"> <html xmlns="http://www.w3.org/1999/xhtml"> <head> <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr68109c0a42cd5-trace').style.display = (document.getElementById('cakeErr68109c0a42cd5-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr68109c0a42cd5-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr68109c0a42cd5-code').style.display = (document.getElementById('cakeErr68109c0a42cd5-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr68109c0a42cd5-context').style.display = (document.getElementById('cakeErr68109c0a42cd5-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr68109c0a42cd5-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700"><</span><span style="color: #0000BB">head</span><span style="color: #007700">> </span></span></code> <span class="code-highlight"><code><span style="color: #000000"> <link rel="canonical" href="<span style="color: #0000BB"><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">); </span><span style="color: #0000BB">?><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-></span><span style="color: #0000BB">category</span><span style="color: #007700">-></span><span style="color: #0000BB">slug</span><span style="color: #007700">; </span><span style="color: #0000BB">?></span>/<span style="color: #0000BB"><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-></span><span style="color: #0000BB">seo_url</span><span style="color: #007700">; </span><span style="color: #0000BB">?></span>.html"/> </span></code></span> <code><span style="color: #000000"><span style="color: #0000BB"> </span><span style="color: #007700"><</span><span style="color: #0000BB">meta http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type" </span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html; charset=utf-8"</span><span style="color: #007700">/> </span></span></code></pre><pre id="cakeErr68109c0a42cd5-context" class="cake-context" style="display: none;">$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp' $dataForView = [ 'article_current' => object(App\Model\Entity\Article) { 'id' => (int) 4310, 'title' => 'UN health agency pushes for better monitoring of anti-malaria drugs', 'subheading' => '', 'description' => '<font face="arial,helvetica,sans-serif" size="3"><br /> </font> <div align="justify"> <font face="arial,helvetica,sans-serif" size="3">Only 34 per cent of countries with endemic malaria are complying with United Nations World Health Organization (WHO) recommendations to routinely monitor anti-malarial medicines, according to a report released today.</font><br /> <br /> <font face="arial,helvetica,sans-serif" size="3">The agency&rsquo;s &ldquo;Global report on anti-malarial drug efficacy and drug resistance: 2000-2010&rdquo; urges countries to be more vigilant in drug monitoring to allow for earlier detection of resistance to anti-malarial treatments.</font><br /> <br /> <font face="arial,helvetica,sans-serif" size="3">&ldquo;A greater political commitment to support and sustain national monitoring of the efficacy of anti-malarial medicines is critical to prevent a wider emergence of artemisinin resistance,&rdquo; said Dr. Pascal Ringwald of the Drug Resistance and Containment Unit, within WHO&rsquo;s Global Malaria Programme and one of the report&rsquo;s authors.</font><br /> <br /> <font face="arial,helvetica,sans-serif" size="3">Artemisinin is currently the most effective treatment against malaria, but resistance to the drug when used alone to treat the disease was found in February 2009 on the Cambodia-Thailand border.</font><br /> <br /> <font face="arial,helvetica,sans-serif" size="3">&ldquo;The emergence of artemisinin resistance on the Cambodia-Thailand border has been a wake-up call to the world to prevent its spread, increase monitoring, and preserve ACTs (Artemisinin-based Combination Therapy) as the only effective treatment we have for falciparum malaria,&rdquo; said Dr. Robert Newman, Director of WHO&rsquo;s Global Malaria Programme.</font><br /> <br /> <font face="arial,helvetica,sans-serif" size="3">Although efforts to contain the spread of artemisinin resistance on the Cambodia-Thailand border are ongoing, early evidence suggests the emergence of resistance on the Myanmar-Thailand border. There is also concern that this resistance could spread from Asia to Africa, as happened with other treatments in the 1960s and 70s.</font><br /> <br /> <font face="arial,helvetica,sans-serif" size="3">&ldquo;Anti-malarial drug resistance is like a cancer, it must be fought at every level,&rdquo; said Nicholas J White, Professor at the Mahidol-Oxford Research Unit in Bangkok, Thailand. &ldquo;Affected countries need to be in the frontline in combating the emergence of drug resistance. WHO should be empowered and supported to take a strong lead. It is crucial to protect ACTs as they are the best treatments for millions of people against malaria.&rdquo;</font><br /> <br /> <font face="arial,helvetica,sans-serif" size="3">The report found that ACTs currently recommended by national malaria control programmes remain effective against malaria, with cure rates generally above 90 per cent. In countries with cure rates lower than 90 per cent, policy change is ongoing to implement efficacious replacement malaria treatments.</font><br /> <br /> <font face="arial,helvetica,sans-serif" size="3">The use of artemisinin monotherapy is considered an important factor in the survival and spread of drug resistant strains. If the efficacy of the artemisinin component continues to decline, the risk grows of increased resistance to other drugs used in the combination.</font><br /> <br /> <font face="arial,helvetica,sans-serif" size="3">In response to the findings in the report, WHO is working with partners to develop a Global Plan for Artemisinin Resistance Containment, which will be released in January 2011. On World Health Day 2011, WHO will launch a public awareness campaign on antimicrobial resistance and its global spread, calling on governments and stakeholders to implement the policies and practices needed to safeguard medicines for future generations.</font><br /> <br /> </div>', 'credit_writer' => 'The United Nations, 18 November, 2010, http://www.un.org/apps/news/story.asp?NewsID=36794&Cr=malaria&Cr1=', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'un-health-agency-pushes-for-better-monitoring-of-anti-malaria-drugs-4401', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 4401, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [ [maximum depth reached] ], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ [maximum depth reached] ], '[dirty]' => [[maximum depth reached]], '[original]' => [[maximum depth reached]], '[virtual]' => [[maximum depth reached]], '[hasErrors]' => false, '[errors]' => [[maximum depth reached]], '[invalid]' => [[maximum depth reached]], '[repository]' => 'Articles' }, 'articleid' => (int) 4310, 'metaTitle' => 'LATEST NEWS UPDATES | UN health agency pushes for better monitoring of anti-malaria drugs', 'metaKeywords' => 'Health', 'metaDesc' => ' Only 34 per cent of countries with endemic malaria are complying with United Nations World Health Organization (WHO) recommendations to routinely monitor anti-malarial medicines, according to a report released today. The agency&rsquo;s &ldquo;Global report on anti-malarial drug efficacy and drug resistance:...', 'disp' => '<font ><br /></font><div align="justify"><font >Only 34 per cent of countries with endemic malaria are complying with United Nations World Health Organization (WHO) recommendations to routinely monitor anti-malarial medicines, according to a report released today.</font><br /><br /><font >The agency&rsquo;s &ldquo;Global report on anti-malarial drug efficacy and drug resistance: 2000-2010&rdquo; urges countries to be more vigilant in drug monitoring to allow for earlier detection of resistance to anti-malarial treatments.</font><br /><br /><font >&ldquo;A greater political commitment to support and sustain national monitoring of the efficacy of anti-malarial medicines is critical to prevent a wider emergence of artemisinin resistance,&rdquo; said Dr. Pascal Ringwald of the Drug Resistance and Containment Unit, within WHO&rsquo;s Global Malaria Programme and one of the report&rsquo;s authors.</font><br /><br /><font >Artemisinin is currently the most effective treatment against malaria, but resistance to the drug when used alone to treat the disease was found in February 2009 on the Cambodia-Thailand border.</font><br /><br /><font >&ldquo;The emergence of artemisinin resistance on the Cambodia-Thailand border has been a wake-up call to the world to prevent its spread, increase monitoring, and preserve ACTs (Artemisinin-based Combination Therapy) as the only effective treatment we have for falciparum malaria,&rdquo; said Dr. Robert Newman, Director of WHO&rsquo;s Global Malaria Programme.</font><br /><br /><font >Although efforts to contain the spread of artemisinin resistance on the Cambodia-Thailand border are ongoing, early evidence suggests the emergence of resistance on the Myanmar-Thailand border. There is also concern that this resistance could spread from Asia to Africa, as happened with other treatments in the 1960s and 70s.</font><br /><br /><font >&ldquo;Anti-malarial drug resistance is like a cancer, it must be fought at every level,&rdquo; said Nicholas J White, Professor at the Mahidol-Oxford Research Unit in Bangkok, Thailand. &ldquo;Affected countries need to be in the frontline in combating the emergence of drug resistance. WHO should be empowered and supported to take a strong lead. It is crucial to protect ACTs as they are the best treatments for millions of people against malaria.&rdquo;</font><br /><br /><font >The report found that ACTs currently recommended by national malaria control programmes remain effective against malaria, with cure rates generally above 90 per cent. In countries with cure rates lower than 90 per cent, policy change is ongoing to implement efficacious replacement malaria treatments.</font><br /><br /><font >The use of artemisinin monotherapy is considered an important factor in the survival and spread of drug resistant strains. If the efficacy of the artemisinin component continues to decline, the risk grows of increased resistance to other drugs used in the combination.</font><br /><br /><font >In response to the findings in the report, WHO is working with partners to develop a Global Plan for Artemisinin Resistance Containment, which will be released in January 2011. On World Health Day 2011, WHO will launch a public awareness campaign on antimicrobial resistance and its global spread, calling on governments and stakeholders to implement the policies and practices needed to safeguard medicines for future generations.</font><br /><br /></div>', 'lang' => 'English', 'SITE_URL' => 'https://im4change.in/', 'site_title' => 'im4change', 'adminprix' => 'admin' ] $article_current = object(App\Model\Entity\Article) { 'id' => (int) 4310, 'title' => 'UN health agency pushes for better monitoring of anti-malaria drugs', 'subheading' => '', 'description' => '<font face="arial,helvetica,sans-serif" size="3"><br /> </font> <div align="justify"> <font face="arial,helvetica,sans-serif" size="3">Only 34 per cent of countries with endemic malaria are complying with United Nations World Health Organization (WHO) recommendations to routinely monitor anti-malarial medicines, according to a report released today.</font><br /> <br /> <font face="arial,helvetica,sans-serif" size="3">The agency&rsquo;s &ldquo;Global report on anti-malarial drug efficacy and drug resistance: 2000-2010&rdquo; urges countries to be more vigilant in drug monitoring to allow for earlier detection of resistance to anti-malarial treatments.</font><br /> <br /> <font face="arial,helvetica,sans-serif" size="3">&ldquo;A greater political commitment to support and sustain national monitoring of the efficacy of anti-malarial medicines is critical to prevent a wider emergence of artemisinin resistance,&rdquo; said Dr. Pascal Ringwald of the Drug Resistance and Containment Unit, within WHO&rsquo;s Global Malaria Programme and one of the report&rsquo;s authors.</font><br /> <br /> <font face="arial,helvetica,sans-serif" size="3">Artemisinin is currently the most effective treatment against malaria, but resistance to the drug when used alone to treat the disease was found in February 2009 on the Cambodia-Thailand border.</font><br /> <br /> <font face="arial,helvetica,sans-serif" size="3">&ldquo;The emergence of artemisinin resistance on the Cambodia-Thailand border has been a wake-up call to the world to prevent its spread, increase monitoring, and preserve ACTs (Artemisinin-based Combination Therapy) as the only effective treatment we have for falciparum malaria,&rdquo; said Dr. Robert Newman, Director of WHO&rsquo;s Global Malaria Programme.</font><br /> <br /> <font face="arial,helvetica,sans-serif" size="3">Although efforts to contain the spread of artemisinin resistance on the Cambodia-Thailand border are ongoing, early evidence suggests the emergence of resistance on the Myanmar-Thailand border. There is also concern that this resistance could spread from Asia to Africa, as happened with other treatments in the 1960s and 70s.</font><br /> <br /> <font face="arial,helvetica,sans-serif" size="3">&ldquo;Anti-malarial drug resistance is like a cancer, it must be fought at every level,&rdquo; said Nicholas J White, Professor at the Mahidol-Oxford Research Unit in Bangkok, Thailand. &ldquo;Affected countries need to be in the frontline in combating the emergence of drug resistance. WHO should be empowered and supported to take a strong lead. It is crucial to protect ACTs as they are the best treatments for millions of people against malaria.&rdquo;</font><br /> <br /> <font face="arial,helvetica,sans-serif" size="3">The report found that ACTs currently recommended by national malaria control programmes remain effective against malaria, with cure rates generally above 90 per cent. In countries with cure rates lower than 90 per cent, policy change is ongoing to implement efficacious replacement malaria treatments.</font><br /> <br /> <font face="arial,helvetica,sans-serif" size="3">The use of artemisinin monotherapy is considered an important factor in the survival and spread of drug resistant strains. If the efficacy of the artemisinin component continues to decline, the risk grows of increased resistance to other drugs used in the combination.</font><br /> <br /> <font face="arial,helvetica,sans-serif" size="3">In response to the findings in the report, WHO is working with partners to develop a Global Plan for Artemisinin Resistance Containment, which will be released in January 2011. On World Health Day 2011, WHO will launch a public awareness campaign on antimicrobial resistance and its global spread, calling on governments and stakeholders to implement the policies and practices needed to safeguard medicines for future generations.</font><br /> <br /> </div>', 'credit_writer' => 'The United Nations, 18 November, 2010, http://www.un.org/apps/news/story.asp?NewsID=36794&Cr=malaria&Cr1=', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'un-health-agency-pushes-for-better-monitoring-of-anti-malaria-drugs-4401', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 4401, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [ (int) 0 => object(Cake\ORM\Entity) {} ], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ '*' => true, 'id' => false ], '[dirty]' => [], '[original]' => [], '[virtual]' => [], '[hasErrors]' => false, '[errors]' => [], '[invalid]' => [], '[repository]' => 'Articles' } $articleid = (int) 4310 $metaTitle = 'LATEST NEWS UPDATES | UN health agency pushes for better monitoring of anti-malaria drugs' $metaKeywords = 'Health' $metaDesc = ' Only 34 per cent of countries with endemic malaria are complying with United Nations World Health Organization (WHO) recommendations to routinely monitor anti-malarial medicines, according to a report released today. The agency&rsquo;s &ldquo;Global report on anti-malarial drug efficacy and drug resistance:...' $disp = '<font ><br /></font><div align="justify"><font >Only 34 per cent of countries with endemic malaria are complying with United Nations World Health Organization (WHO) recommendations to routinely monitor anti-malarial medicines, according to a report released today.</font><br /><br /><font >The agency&rsquo;s &ldquo;Global report on anti-malarial drug efficacy and drug resistance: 2000-2010&rdquo; urges countries to be more vigilant in drug monitoring to allow for earlier detection of resistance to anti-malarial treatments.</font><br /><br /><font >&ldquo;A greater political commitment to support and sustain national monitoring of the efficacy of anti-malarial medicines is critical to prevent a wider emergence of artemisinin resistance,&rdquo; said Dr. Pascal Ringwald of the Drug Resistance and Containment Unit, within WHO&rsquo;s Global Malaria Programme and one of the report&rsquo;s authors.</font><br /><br /><font >Artemisinin is currently the most effective treatment against malaria, but resistance to the drug when used alone to treat the disease was found in February 2009 on the Cambodia-Thailand border.</font><br /><br /><font >&ldquo;The emergence of artemisinin resistance on the Cambodia-Thailand border has been a wake-up call to the world to prevent its spread, increase monitoring, and preserve ACTs (Artemisinin-based Combination Therapy) as the only effective treatment we have for falciparum malaria,&rdquo; said Dr. Robert Newman, Director of WHO&rsquo;s Global Malaria Programme.</font><br /><br /><font >Although efforts to contain the spread of artemisinin resistance on the Cambodia-Thailand border are ongoing, early evidence suggests the emergence of resistance on the Myanmar-Thailand border. There is also concern that this resistance could spread from Asia to Africa, as happened with other treatments in the 1960s and 70s.</font><br /><br /><font >&ldquo;Anti-malarial drug resistance is like a cancer, it must be fought at every level,&rdquo; said Nicholas J White, Professor at the Mahidol-Oxford Research Unit in Bangkok, Thailand. &ldquo;Affected countries need to be in the frontline in combating the emergence of drug resistance. WHO should be empowered and supported to take a strong lead. It is crucial to protect ACTs as they are the best treatments for millions of people against malaria.&rdquo;</font><br /><br /><font >The report found that ACTs currently recommended by national malaria control programmes remain effective against malaria, with cure rates generally above 90 per cent. In countries with cure rates lower than 90 per cent, policy change is ongoing to implement efficacious replacement malaria treatments.</font><br /><br /><font >The use of artemisinin monotherapy is considered an important factor in the survival and spread of drug resistant strains. If the efficacy of the artemisinin component continues to decline, the risk grows of increased resistance to other drugs used in the combination.</font><br /><br /><font >In response to the findings in the report, WHO is working with partners to develop a Global Plan for Artemisinin Resistance Containment, which will be released in January 2011. On World Health Day 2011, WHO will launch a public awareness campaign on antimicrobial resistance and its global spread, calling on governments and stakeholders to implement the policies and practices needed to safeguard medicines for future generations.</font><br /><br /></div>' $lang = 'English' $SITE_URL = 'https://im4change.in/' $site_title = 'im4change' $adminprix = 'admin'</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8 Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413 Cake\View\View::_render() - CORE/src/View/View.php, line 1374 Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927 Cake\View\View::render() - CORE/src/View/View.php, line 885 Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791 Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126 Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94 Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/un-health-agency-pushes-for-better-monitoring-of-anti-malaria-drugs-4401.html"/> <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/> <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css" media="all"/> <title>LATEST NEWS UPDATES | UN health agency pushes for better monitoring of anti-malaria drugs | Im4change.org</title> <meta name="description" content=" Only 34 per cent of countries with endemic malaria are complying with United Nations World Health Organization (WHO) recommendations to routinely monitor anti-malarial medicines, according to a report released today. The agency’s “Global report on anti-malarial drug efficacy and drug resistance:..."/> <script src="https://im4change.in/js/jquery-1.10.2.js"></script> <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script> <script language="javascript" type="text/javascript"> $(document).ready(function () { var img = $("img")[0]; // Get my img elem var pic_real_width, pic_real_height; $("<img/>") // Make in memory copy of image to avoid css issues .attr("src", $(img).attr("src")) .load(function () { pic_real_width = this.width; // Note: $(this).width() will not pic_real_height = this.height; // work for in memory images. }); }); </script> <style type="text/css"> @media screen { div.divFooter { display: block; } } @media print { .printbutton { display: none !important; } } </style> </head> <body> <table cellpadding="0" cellspacing="0" border="0" width="98%" align="center"> <tr> <td class="top_bg"> <div class="divFooter"> <img src="https://im4change.in/images/logo1.jpg" height="59" border="0" alt="Resource centre on India's rural distress" style="padding-top:14px;"/> </div> </td> </tr> <tr> <td id="topspace"> </td> </tr> <tr id="topspace"> <td> </td> </tr> <tr> <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton"> <form><input type="button" value=" Print this page " onclick="window.print();return false;"/></form> </td> </tr> <tr> <td width="100%"> <h1 class="news_headlines" style="font-style:normal"> <strong>UN health agency pushes for better monitoring of anti-malaria drugs</strong></h1> </td> </tr> <tr> <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3"> <font ><br /></font><div align="justify"><font >Only 34 per cent of countries with endemic malaria are complying with United Nations World Health Organization (WHO) recommendations to routinely monitor anti-malarial medicines, according to a report released today.</font><br /><br /><font >The agency’s “Global report on anti-malarial drug efficacy and drug resistance: 2000-2010” urges countries to be more vigilant in drug monitoring to allow for earlier detection of resistance to anti-malarial treatments.</font><br /><br /><font >“A greater political commitment to support and sustain national monitoring of the efficacy of anti-malarial medicines is critical to prevent a wider emergence of artemisinin resistance,” said Dr. Pascal Ringwald of the Drug Resistance and Containment Unit, within WHO’s Global Malaria Programme and one of the report’s authors.</font><br /><br /><font >Artemisinin is currently the most effective treatment against malaria, but resistance to the drug when used alone to treat the disease was found in February 2009 on the Cambodia-Thailand border.</font><br /><br /><font >“The emergence of artemisinin resistance on the Cambodia-Thailand border has been a wake-up call to the world to prevent its spread, increase monitoring, and preserve ACTs (Artemisinin-based Combination Therapy) as the only effective treatment we have for falciparum malaria,” said Dr. Robert Newman, Director of WHO’s Global Malaria Programme.</font><br /><br /><font >Although efforts to contain the spread of artemisinin resistance on the Cambodia-Thailand border are ongoing, early evidence suggests the emergence of resistance on the Myanmar-Thailand border. There is also concern that this resistance could spread from Asia to Africa, as happened with other treatments in the 1960s and 70s.</font><br /><br /><font >“Anti-malarial drug resistance is like a cancer, it must be fought at every level,” said Nicholas J White, Professor at the Mahidol-Oxford Research Unit in Bangkok, Thailand. “Affected countries need to be in the frontline in combating the emergence of drug resistance. WHO should be empowered and supported to take a strong lead. It is crucial to protect ACTs as they are the best treatments for millions of people against malaria.”</font><br /><br /><font >The report found that ACTs currently recommended by national malaria control programmes remain effective against malaria, with cure rates generally above 90 per cent. In countries with cure rates lower than 90 per cent, policy change is ongoing to implement efficacious replacement malaria treatments.</font><br /><br /><font >The use of artemisinin monotherapy is considered an important factor in the survival and spread of drug resistant strains. If the efficacy of the artemisinin component continues to decline, the risk grows of increased resistance to other drugs used in the combination.</font><br /><br /><font >In response to the findings in the report, WHO is working with partners to develop a Global Plan for Artemisinin Resistance Containment, which will be released in January 2011. On World Health Day 2011, WHO will launch a public awareness campaign on antimicrobial resistance and its global spread, calling on governments and stakeholders to implement the policies and practices needed to safeguard medicines for future generations.</font><br /><br /></div> </font> </td> </tr> <tr> <td> </td> </tr> <tr> <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;"> <form><input type="button" value=" Print this page " onclick="window.print();return false;"/></form> </td> </tr> </table></body> </html>' } $cookies = [] $values = [ (int) 0 => 'text/html; charset=UTF-8' ] $name = 'Content-Type' $first = true $value = 'text/html; charset=UTF-8'header - [internal], line ?? Cake\Http\ResponseEmitter::emitHeaders() - CORE/src/Http/ResponseEmitter.php, line 181 Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 55 Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141 [main] - ROOT/webroot/index.php, line 39
<head>
<link rel="canonical" href="<?php echo Configure::read('SITE_URL'); ?><?php echo $urlPrefix;?><?php echo $article_current->category->slug; ?>/<?php echo $article_current->seo_url; ?>.html"/>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp' $dataForView = [ 'article_current' => object(App\Model\Entity\Article) { 'id' => (int) 4310, 'title' => 'UN health agency pushes for better monitoring of anti-malaria drugs', 'subheading' => '', 'description' => '<font face="arial,helvetica,sans-serif" size="3"><br /> </font> <div align="justify"> <font face="arial,helvetica,sans-serif" size="3">Only 34 per cent of countries with endemic malaria are complying with United Nations World Health Organization (WHO) recommendations to routinely monitor anti-malarial medicines, according to a report released today.</font><br /> <br /> <font face="arial,helvetica,sans-serif" size="3">The agency’s “Global report on anti-malarial drug efficacy and drug resistance: 2000-2010” urges countries to be more vigilant in drug monitoring to allow for earlier detection of resistance to anti-malarial treatments.</font><br /> <br /> <font face="arial,helvetica,sans-serif" size="3">“A greater political commitment to support and sustain national monitoring of the efficacy of anti-malarial medicines is critical to prevent a wider emergence of artemisinin resistance,” said Dr. Pascal Ringwald of the Drug Resistance and Containment Unit, within WHO’s Global Malaria Programme and one of the report’s authors.</font><br /> <br /> <font face="arial,helvetica,sans-serif" size="3">Artemisinin is currently the most effective treatment against malaria, but resistance to the drug when used alone to treat the disease was found in February 2009 on the Cambodia-Thailand border.</font><br /> <br /> <font face="arial,helvetica,sans-serif" size="3">“The emergence of artemisinin resistance on the Cambodia-Thailand border has been a wake-up call to the world to prevent its spread, increase monitoring, and preserve ACTs (Artemisinin-based Combination Therapy) as the only effective treatment we have for falciparum malaria,” said Dr. Robert Newman, Director of WHO’s Global Malaria Programme.</font><br /> <br /> <font face="arial,helvetica,sans-serif" size="3">Although efforts to contain the spread of artemisinin resistance on the Cambodia-Thailand border are ongoing, early evidence suggests the emergence of resistance on the Myanmar-Thailand border. There is also concern that this resistance could spread from Asia to Africa, as happened with other treatments in the 1960s and 70s.</font><br /> <br /> <font face="arial,helvetica,sans-serif" size="3">“Anti-malarial drug resistance is like a cancer, it must be fought at every level,” said Nicholas J White, Professor at the Mahidol-Oxford Research Unit in Bangkok, Thailand. “Affected countries need to be in the frontline in combating the emergence of drug resistance. WHO should be empowered and supported to take a strong lead. It is crucial to protect ACTs as they are the best treatments for millions of people against malaria.”</font><br /> <br /> <font face="arial,helvetica,sans-serif" size="3">The report found that ACTs currently recommended by national malaria control programmes remain effective against malaria, with cure rates generally above 90 per cent. In countries with cure rates lower than 90 per cent, policy change is ongoing to implement efficacious replacement malaria treatments.</font><br /> <br /> <font face="arial,helvetica,sans-serif" size="3">The use of artemisinin monotherapy is considered an important factor in the survival and spread of drug resistant strains. If the efficacy of the artemisinin component continues to decline, the risk grows of increased resistance to other drugs used in the combination.</font><br /> <br /> <font face="arial,helvetica,sans-serif" size="3">In response to the findings in the report, WHO is working with partners to develop a Global Plan for Artemisinin Resistance Containment, which will be released in January 2011. On World Health Day 2011, WHO will launch a public awareness campaign on antimicrobial resistance and its global spread, calling on governments and stakeholders to implement the policies and practices needed to safeguard medicines for future generations.</font><br /> <br /> </div>', 'credit_writer' => 'The United Nations, 18 November, 2010, http://www.un.org/apps/news/story.asp?NewsID=36794&Cr=malaria&Cr1=', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'un-health-agency-pushes-for-better-monitoring-of-anti-malaria-drugs-4401', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 4401, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [ [maximum depth reached] ], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ [maximum depth reached] ], '[dirty]' => [[maximum depth reached]], '[original]' => [[maximum depth reached]], '[virtual]' => [[maximum depth reached]], '[hasErrors]' => false, '[errors]' => [[maximum depth reached]], '[invalid]' => [[maximum depth reached]], '[repository]' => 'Articles' }, 'articleid' => (int) 4310, 'metaTitle' => 'LATEST NEWS UPDATES | UN health agency pushes for better monitoring of anti-malaria drugs', 'metaKeywords' => 'Health', 'metaDesc' => ' Only 34 per cent of countries with endemic malaria are complying with United Nations World Health Organization (WHO) recommendations to routinely monitor anti-malarial medicines, according to a report released today. The agency’s “Global report on anti-malarial drug efficacy and drug resistance:...', 'disp' => '<font ><br /></font><div align="justify"><font >Only 34 per cent of countries with endemic malaria are complying with United Nations World Health Organization (WHO) recommendations to routinely monitor anti-malarial medicines, according to a report released today.</font><br /><br /><font >The agency’s “Global report on anti-malarial drug efficacy and drug resistance: 2000-2010” urges countries to be more vigilant in drug monitoring to allow for earlier detection of resistance to anti-malarial treatments.</font><br /><br /><font >“A greater political commitment to support and sustain national monitoring of the efficacy of anti-malarial medicines is critical to prevent a wider emergence of artemisinin resistance,” said Dr. Pascal Ringwald of the Drug Resistance and Containment Unit, within WHO’s Global Malaria Programme and one of the report’s authors.</font><br /><br /><font >Artemisinin is currently the most effective treatment against malaria, but resistance to the drug when used alone to treat the disease was found in February 2009 on the Cambodia-Thailand border.</font><br /><br /><font >“The emergence of artemisinin resistance on the Cambodia-Thailand border has been a wake-up call to the world to prevent its spread, increase monitoring, and preserve ACTs (Artemisinin-based Combination Therapy) as the only effective treatment we have for falciparum malaria,” said Dr. Robert Newman, Director of WHO’s Global Malaria Programme.</font><br /><br /><font >Although efforts to contain the spread of artemisinin resistance on the Cambodia-Thailand border are ongoing, early evidence suggests the emergence of resistance on the Myanmar-Thailand border. There is also concern that this resistance could spread from Asia to Africa, as happened with other treatments in the 1960s and 70s.</font><br /><br /><font >“Anti-malarial drug resistance is like a cancer, it must be fought at every level,” said Nicholas J White, Professor at the Mahidol-Oxford Research Unit in Bangkok, Thailand. “Affected countries need to be in the frontline in combating the emergence of drug resistance. WHO should be empowered and supported to take a strong lead. It is crucial to protect ACTs as they are the best treatments for millions of people against malaria.”</font><br /><br /><font >The report found that ACTs currently recommended by national malaria control programmes remain effective against malaria, with cure rates generally above 90 per cent. In countries with cure rates lower than 90 per cent, policy change is ongoing to implement efficacious replacement malaria treatments.</font><br /><br /><font >The use of artemisinin monotherapy is considered an important factor in the survival and spread of drug resistant strains. If the efficacy of the artemisinin component continues to decline, the risk grows of increased resistance to other drugs used in the combination.</font><br /><br /><font >In response to the findings in the report, WHO is working with partners to develop a Global Plan for Artemisinin Resistance Containment, which will be released in January 2011. On World Health Day 2011, WHO will launch a public awareness campaign on antimicrobial resistance and its global spread, calling on governments and stakeholders to implement the policies and practices needed to safeguard medicines for future generations.</font><br /><br /></div>', 'lang' => 'English', 'SITE_URL' => 'https://im4change.in/', 'site_title' => 'im4change', 'adminprix' => 'admin' ] $article_current = object(App\Model\Entity\Article) { 'id' => (int) 4310, 'title' => 'UN health agency pushes for better monitoring of anti-malaria drugs', 'subheading' => '', 'description' => '<font face="arial,helvetica,sans-serif" size="3"><br /> </font> <div align="justify"> <font face="arial,helvetica,sans-serif" size="3">Only 34 per cent of countries with endemic malaria are complying with United Nations World Health Organization (WHO) recommendations to routinely monitor anti-malarial medicines, according to a report released today.</font><br /> <br /> <font face="arial,helvetica,sans-serif" size="3">The agency’s “Global report on anti-malarial drug efficacy and drug resistance: 2000-2010” urges countries to be more vigilant in drug monitoring to allow for earlier detection of resistance to anti-malarial treatments.</font><br /> <br /> <font face="arial,helvetica,sans-serif" size="3">“A greater political commitment to support and sustain national monitoring of the efficacy of anti-malarial medicines is critical to prevent a wider emergence of artemisinin resistance,” said Dr. Pascal Ringwald of the Drug Resistance and Containment Unit, within WHO’s Global Malaria Programme and one of the report’s authors.</font><br /> <br /> <font face="arial,helvetica,sans-serif" size="3">Artemisinin is currently the most effective treatment against malaria, but resistance to the drug when used alone to treat the disease was found in February 2009 on the Cambodia-Thailand border.</font><br /> <br /> <font face="arial,helvetica,sans-serif" size="3">“The emergence of artemisinin resistance on the Cambodia-Thailand border has been a wake-up call to the world to prevent its spread, increase monitoring, and preserve ACTs (Artemisinin-based Combination Therapy) as the only effective treatment we have for falciparum malaria,” said Dr. Robert Newman, Director of WHO’s Global Malaria Programme.</font><br /> <br /> <font face="arial,helvetica,sans-serif" size="3">Although efforts to contain the spread of artemisinin resistance on the Cambodia-Thailand border are ongoing, early evidence suggests the emergence of resistance on the Myanmar-Thailand border. There is also concern that this resistance could spread from Asia to Africa, as happened with other treatments in the 1960s and 70s.</font><br /> <br /> <font face="arial,helvetica,sans-serif" size="3">“Anti-malarial drug resistance is like a cancer, it must be fought at every level,” said Nicholas J White, Professor at the Mahidol-Oxford Research Unit in Bangkok, Thailand. “Affected countries need to be in the frontline in combating the emergence of drug resistance. WHO should be empowered and supported to take a strong lead. It is crucial to protect ACTs as they are the best treatments for millions of people against malaria.”</font><br /> <br /> <font face="arial,helvetica,sans-serif" size="3">The report found that ACTs currently recommended by national malaria control programmes remain effective against malaria, with cure rates generally above 90 per cent. In countries with cure rates lower than 90 per cent, policy change is ongoing to implement efficacious replacement malaria treatments.</font><br /> <br /> <font face="arial,helvetica,sans-serif" size="3">The use of artemisinin monotherapy is considered an important factor in the survival and spread of drug resistant strains. If the efficacy of the artemisinin component continues to decline, the risk grows of increased resistance to other drugs used in the combination.</font><br /> <br /> <font face="arial,helvetica,sans-serif" size="3">In response to the findings in the report, WHO is working with partners to develop a Global Plan for Artemisinin Resistance Containment, which will be released in January 2011. On World Health Day 2011, WHO will launch a public awareness campaign on antimicrobial resistance and its global spread, calling on governments and stakeholders to implement the policies and practices needed to safeguard medicines for future generations.</font><br /> <br /> </div>', 'credit_writer' => 'The United Nations, 18 November, 2010, http://www.un.org/apps/news/story.asp?NewsID=36794&Cr=malaria&Cr1=', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'un-health-agency-pushes-for-better-monitoring-of-anti-malaria-drugs-4401', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 4401, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [ (int) 0 => object(Cake\ORM\Entity) {} ], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ '*' => true, 'id' => false ], '[dirty]' => [], '[original]' => [], '[virtual]' => [], '[hasErrors]' => false, '[errors]' => [], '[invalid]' => [], '[repository]' => 'Articles' } $articleid = (int) 4310 $metaTitle = 'LATEST NEWS UPDATES | UN health agency pushes for better monitoring of anti-malaria drugs' $metaKeywords = 'Health' $metaDesc = ' Only 34 per cent of countries with endemic malaria are complying with United Nations World Health Organization (WHO) recommendations to routinely monitor anti-malarial medicines, according to a report released today. The agency’s “Global report on anti-malarial drug efficacy and drug resistance:...' $disp = '<font ><br /></font><div align="justify"><font >Only 34 per cent of countries with endemic malaria are complying with United Nations World Health Organization (WHO) recommendations to routinely monitor anti-malarial medicines, according to a report released today.</font><br /><br /><font >The agency’s “Global report on anti-malarial drug efficacy and drug resistance: 2000-2010” urges countries to be more vigilant in drug monitoring to allow for earlier detection of resistance to anti-malarial treatments.</font><br /><br /><font >“A greater political commitment to support and sustain national monitoring of the efficacy of anti-malarial medicines is critical to prevent a wider emergence of artemisinin resistance,” said Dr. Pascal Ringwald of the Drug Resistance and Containment Unit, within WHO’s Global Malaria Programme and one of the report’s authors.</font><br /><br /><font >Artemisinin is currently the most effective treatment against malaria, but resistance to the drug when used alone to treat the disease was found in February 2009 on the Cambodia-Thailand border.</font><br /><br /><font >“The emergence of artemisinin resistance on the Cambodia-Thailand border has been a wake-up call to the world to prevent its spread, increase monitoring, and preserve ACTs (Artemisinin-based Combination Therapy) as the only effective treatment we have for falciparum malaria,” said Dr. Robert Newman, Director of WHO’s Global Malaria Programme.</font><br /><br /><font >Although efforts to contain the spread of artemisinin resistance on the Cambodia-Thailand border are ongoing, early evidence suggests the emergence of resistance on the Myanmar-Thailand border. There is also concern that this resistance could spread from Asia to Africa, as happened with other treatments in the 1960s and 70s.</font><br /><br /><font >“Anti-malarial drug resistance is like a cancer, it must be fought at every level,” said Nicholas J White, Professor at the Mahidol-Oxford Research Unit in Bangkok, Thailand. “Affected countries need to be in the frontline in combating the emergence of drug resistance. WHO should be empowered and supported to take a strong lead. It is crucial to protect ACTs as they are the best treatments for millions of people against malaria.”</font><br /><br /><font >The report found that ACTs currently recommended by national malaria control programmes remain effective against malaria, with cure rates generally above 90 per cent. In countries with cure rates lower than 90 per cent, policy change is ongoing to implement efficacious replacement malaria treatments.</font><br /><br /><font >The use of artemisinin monotherapy is considered an important factor in the survival and spread of drug resistant strains. If the efficacy of the artemisinin component continues to decline, the risk grows of increased resistance to other drugs used in the combination.</font><br /><br /><font >In response to the findings in the report, WHO is working with partners to develop a Global Plan for Artemisinin Resistance Containment, which will be released in January 2011. On World Health Day 2011, WHO will launch a public awareness campaign on antimicrobial resistance and its global spread, calling on governments and stakeholders to implement the policies and practices needed to safeguard medicines for future generations.</font><br /><br /></div>' $lang = 'English' $SITE_URL = 'https://im4change.in/' $site_title = 'im4change' $adminprix = 'admin'
include - APP/Template/Layout/printlayout.ctp, line 8 Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413 Cake\View\View::_render() - CORE/src/View/View.php, line 1374 Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927 Cake\View\View::render() - CORE/src/View/View.php, line 885 Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791 Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126 Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94 Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
![]() |
UN health agency pushes for better monitoring of anti-malaria drugs |
Only 34 per cent of countries with endemic malaria are complying with United Nations World Health Organization (WHO) recommendations to routinely monitor anti-malarial medicines, according to a report released today.
The agency’s “Global report on anti-malarial drug efficacy and drug resistance: 2000-2010” urges countries to be more vigilant in drug monitoring to allow for earlier detection of resistance to anti-malarial treatments. “A greater political commitment to support and sustain national monitoring of the efficacy of anti-malarial medicines is critical to prevent a wider emergence of artemisinin resistance,” said Dr. Pascal Ringwald of the Drug Resistance and Containment Unit, within WHO’s Global Malaria Programme and one of the report’s authors. Artemisinin is currently the most effective treatment against malaria, but resistance to the drug when used alone to treat the disease was found in February 2009 on the Cambodia-Thailand border. “The emergence of artemisinin resistance on the Cambodia-Thailand border has been a wake-up call to the world to prevent its spread, increase monitoring, and preserve ACTs (Artemisinin-based Combination Therapy) as the only effective treatment we have for falciparum malaria,” said Dr. Robert Newman, Director of WHO’s Global Malaria Programme. Although efforts to contain the spread of artemisinin resistance on the Cambodia-Thailand border are ongoing, early evidence suggests the emergence of resistance on the Myanmar-Thailand border. There is also concern that this resistance could spread from Asia to Africa, as happened with other treatments in the 1960s and 70s. “Anti-malarial drug resistance is like a cancer, it must be fought at every level,” said Nicholas J White, Professor at the Mahidol-Oxford Research Unit in Bangkok, Thailand. “Affected countries need to be in the frontline in combating the emergence of drug resistance. WHO should be empowered and supported to take a strong lead. It is crucial to protect ACTs as they are the best treatments for millions of people against malaria.” The report found that ACTs currently recommended by national malaria control programmes remain effective against malaria, with cure rates generally above 90 per cent. In countries with cure rates lower than 90 per cent, policy change is ongoing to implement efficacious replacement malaria treatments. The use of artemisinin monotherapy is considered an important factor in the survival and spread of drug resistant strains. If the efficacy of the artemisinin component continues to decline, the risk grows of increased resistance to other drugs used in the combination. In response to the findings in the report, WHO is working with partners to develop a Global Plan for Artemisinin Resistance Containment, which will be released in January 2011. On World Health Day 2011, WHO will launch a public awareness campaign on antimicrobial resistance and its global spread, calling on governments and stakeholders to implement the policies and practices needed to safeguard medicines for future generations. |